by | May 16, 2024 | Publications
Leuk Lymphoma. 2024 May 15:1-12. doi: 10.1080/10428194.2024.2352086. Online ahead of print. ABSTRACT The concept of time toxicity in oncology refers to the presence of frequent healthcare-related interactions that can interfere with patient well-being. In this review,...
by | May 15, 2024 | Publications
Pol Arch Intern Med. 2024 May 14:16749. doi: 10.20452/pamw.16749. Online ahead of print. NO ABSTRACT PMID:38747414 | DOI:10.20452/pamw.16749
by | May 15, 2024 | Publications
Am J Hematol. 2024 May 15. doi: 10.1002/ajh.27364. Online ahead of print. ABSTRACT Smoldering multiple myeloma (SMM) is a precursor stage that precedes multiple myeloma (MM). SMM is heterogenous with nearly 40% of patients progressing to MM in the first 5 years. The...
by | May 15, 2024 | Publications
Cancer Res Commun. 2024 May 15. doi: 10.1158/2767-9764.CRC-23-0528. Online ahead of print. ABSTRACT Proteasomes degrade intracellular proteins to generate antigenic peptides that are recognized by the adaptive immune system and promote anticancer immunity. However,...
by | May 15, 2024 | Publications
Clin Lab. 2024 May 1;70(5). doi: 10.7754/Clin.Lab.2023.231215. ABSTRACT BACKGROUND: For many years it has been postulated that the immune system controls the progress of multiple myeloma (MM). However, the phenotypes of T cells in MM remain to be elucidated. In this...
by | May 15, 2024 | Publications
Clin Cancer Res. 2024 May 15;30(10):2288. doi: 10.1158/1078-0432.CCR-24-1089. NO ABSTRACT PMID:38745477 | DOI:10.1158/1078-0432.CCR-24-1089
